Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000732303 | SCV000533152 | likely benign | not provided | 2018-06-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080112 | SCV000631763 | benign | Alstrom syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000732303 | SCV000860236 | uncertain significance | not provided | 2018-03-27 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000424426 | SCV001363028 | likely benign | not specified | 2019-11-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000732303 | SCV002544051 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BP7 |
Ambry Genetics | RCV002379371 | SCV002674122 | likely benign | Cardiovascular phenotype | 2020-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |